References
- American Thoracic Society, European Respiratory SocietyStandards for the Diagnosis and Management of Patients With COPD2004 Available from: http://www.thoracic.org/clinical/copd-guidelines/resources/copddoc.pdfAccessed February 5, 2015
- Centers for Disease Control and Prevention (CDC)Chronic obstructive pulmonary disease among adults – United StatesMorb Mort Wkly Rep20116146938943
- HoyertDLXuJDeaths: preliminary data for 2011Natl Vital Stat Rep2012616151 Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_06.pdfAccessed February 5, 201524984457
- American Thoracic SocietyWhat Is an Exacerbation Available from: http://www.thoracic.org/clinical/copd-guidelines/for-patients/what-is-an-exacerbation.phpAccessed February 5, 2015
- HalpinDMDecramerMCelliBKestenSLiuDTashkinDPExacerbation frequency and course of COPDInt J Chron Obstruct Pulmon Dis2012765366123055714
- MakrisDMoschandreasJDamianakiAExacerbations and lung function decline in COPD: new insights in current and ex-smokersRespir Med200710161305131217112715
- HoogendoornMFeenstraTLHoogenveenRTAlMMolkenMRAssociation between lung function and exacerbation frequency in patients with COPDInt J Chron Obstruct Pulmon Dis2010543544421191438
- HurstJRVestboJAnzuetoAFor the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
- Global Initiative for Chronic Obstructive Lung Disease, IGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease2014 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdfAccessed February 5, 2015
- PereraPNArmstrongEPSherrillDLSkrepnekGHAcute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortalityCOPD20129213114122409371
- ToyELGallagherKFStanleyELSwensenARDuhMSThe economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a reviewCOPD20107321422820486821
- Centre for Disease Control and PreventionChronic obstructive pulmonary disease among adults – United States, 2011MMWR2012614693894323169314
- DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
- U.S. Department of Labor, Bureau of Labor StatisticsMeasuring Price Change for Medical Care in the CPIWashington, DCBLS2010
- PasqualeMKSunSXSongFHartnettHJStemkowskiSAImpact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis2012775776423152680
- PunekarYSShuklaAMüllerovaHCOPD management costs according to the frequency of COPD exacerbations in UK primary careInt J Chron Obstruct Pulmon Dis20149657324426781
- DalalAAPatelJD’SouzaAFarrellyENagarSShahMImpact of COPD exacerbation frequency on costs for a managed care populationJ Manag Care Spec Pharm201521757558326108382
- AnderssonFBorgSJanssonSAThe costs of exacerbations in chronic obstructive pulmonary disease (COPD)Respir Med200296970070812243316
- FordESMurphyLBKhavjouOGilesWHHoltJBCroftJBTotal and state-specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020Chest20151471314525058738
- Spiriva® [package insert]Boehringer Ingelheim Pharmaceuticals, IncRidgefield, CT2014 Available from: http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Spiriva/Spiriva.pdf
- Advair Diskus® [package insert]AdvairGlaxoSmithKline, Research Triangle Park, NC2014 Available from: https://www.gsksource.com/gskprm/htdocs/documents/ADVAIR-DISKUS-PI-MG.PDF